When adjusting for confounders for MFAP4 levels, (CID, age, sex, smoking status and BMI), High MFAP4 showed a positive association with treatment outcome in all CIDs except Crohn’s disease, enabling High MFAP4 as a potential biomarker for biological treatment response. Here, MFAP4 is linked to Crohn disease.